113 related articles for article (PubMed ID: 6349864)
1. Increased secretion of insulin but unchanged secretion of growth hormone in hyperglycaemic type II diabetics treated with acetyl-salicylic acid.
Vierhapper H; Bratusch-Marrain P; Waldhäusl W; Nowotny P; Panzer S
Clin Endocrinol (Oxf); 1983 Jun; 18(6):613-9. PubMed ID: 6349864
[TBL] [Abstract][Full Text] [Related]
2. Impact of euglycaemia and hyperglycaemia on the release of growth hormone and prolactin in type II-diabetics.
Vierhapper H; Bratusch-Marrain P; Waldhäusl W; Nowotny P; Panzer S
Horm Metab Res; 1983 Jan; 15(1):24-9. PubMed ID: 6403444
[TBL] [Abstract][Full Text] [Related]
3. Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man.
Bratusch-Marrain PR; Vierhapper H; Komjati M; Waldhäusl WK
Diabetologia; 1985 Sep; 28(9):671-6. PubMed ID: 3905478
[TBL] [Abstract][Full Text] [Related]
4. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.
Maccario M; Grottoli S; Razzore P; Procopio M; Oleandri SE; Ciccarelli E; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Aug; 135(2):205-10. PubMed ID: 8810734
[TBL] [Abstract][Full Text] [Related]
6. The impact of euglycemia and hyperglycemia on stimulated pituitary hormone release in insulin-dependent diabetics.
Vierhapper H; Grubeck-Loebenstein B; Bratusch-Marrain P; Panzer S; Waldhäusl W
J Clin Endocrinol Metab; 1981 Jun; 52(6):1230-4. PubMed ID: 6785297
[TBL] [Abstract][Full Text] [Related]
7. Arginine-induced insulin and growth hormone secretion in children with nutritional rickets.
Soliman AT; Aref MK; Rogol AD
J Pediatr Gastroenterol Nutr; 1987; 6(4):589-92. PubMed ID: 3323444
[TBL] [Abstract][Full Text] [Related]
8. On the diabetogenic effect of growth hormone in man: effects of growth hormone of glucagon and insulin secretion.
Adamson U
Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):115-9. PubMed ID: 6785095
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
[TBL] [Abstract][Full Text] [Related]
10. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
11. Influence of lysine acetyl-salicylate on glucose and arginine stimulated insulin release in man.
van Haeften TW; Veneman TF; van der Veen EA
Horm Metab Res; 1991 Apr; 23(4):168-70. PubMed ID: 1908430
[TBL] [Abstract][Full Text] [Related]
12. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
Ferrero E; Casale G; Tassi G; Ciaponi A
Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
[TBL] [Abstract][Full Text] [Related]
13. [Insulin resistance and insulin secretion in type II non-obese diabetics].
Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
[TBL] [Abstract][Full Text] [Related]
14. Impaired insulin secretion in human diabetes mellitus. II. A possible role for prostaglandins.
Giugliano D; Sgamboto S; Coppola L; Misso L; Torella R
Prostaglandins Med; 1981 Jan; 6(1):41-50. PubMed ID: 6784135
[TBL] [Abstract][Full Text] [Related]
15. [Effect of amino acids on the secretion of growth hormone and insulin in healthy persons and diabetics].
Waldhäusl W; Beringer A
Klin Wochenschr; 1969 Apr; 47(7):359-63. PubMed ID: 5383388
[No Abstract] [Full Text] [Related]
16. Repetitive stimulation of insulin secretion with arginine and glucose.
Van Haeften TW; Van Faassen I; Van der Veen EA
Diabetes Res; 1988 Dec; 9(4):187-91. PubMed ID: 3073905
[TBL] [Abstract][Full Text] [Related]
17. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
Shimoda S; Takemura Y; Ieiri T; Kasai K; Kikuchi T
Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):9-17. PubMed ID: 1171032
[TBL] [Abstract][Full Text] [Related]
18. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.
Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M
J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951
[TBL] [Abstract][Full Text] [Related]
19. [Test meals in normal subjects and in treated diabetics].
Tchobroutsky G
Presse Med (1893); 1970 Jun; 78(30):1359-64. PubMed ID: 5421552
[No Abstract] [Full Text] [Related]
20. Effects of arginine aspartate and its components on growth hormone, insulin and glucagon secretion in the rat.
Franchimont P; Campistron G; Creuzet MH; Gros J; Luyckx A
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):161-8. PubMed ID: 6372719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
